TY - JOUR T1 - Highlights from this issue JF - Practical Neurology JO - Pract Neurol SP - 157 LP - 157 DO - 10.1136/practneurol-2015-001170 VL - 15 IS - 3 AU - Phil Smith AU - Geraint N Fuller Y1 - 2015/06/01 UR - http://pn.bmj.com/content/15/3/157.abstract N2 - How should we best manage a patient with myasthenia gravis? This issue includes a guideline prepared by Jon Sussman and colleagues from the Association of British Neurologists (ABN) myasthenia section (see page 199). For most guidelines, a development group's biggest task is to sift through multiple clinical trials and meta-analyses to grade evidence and to arrive at the best advice, based on the best data, while highlighting conflicts of interest. The very few randomised clinical trials in myasthenia left this group with a different task—to provide the best pragmatic guidance on the information available. Their objective was, in effect, to bring the myasthenia section members into clinic with you. What would the experts do for your patient? This should tell you, in a format that hopefully you find useful. AGREE II criteria1 are used assess the quality of clinical guidelines—particularly their development process—and our website has just such … ER -